Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DOMINIC V BARBERIO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1598818536
CMS profile
344942
Location
LANSING, MI

General Payments · PY2018–2024

$7,116.70

  • Reported across 421 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$609.78

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $609.78 32

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alkermes, Inc. $168.52 5
ITI, Inc. $141.80 12
Otsuka America Pharmaceutical, Inc. $91.70 5
Neurocrine BioSciences, Inc. $56.64 2
Indivior Inc. $49.21 2
Lundbeck LLC $44.77 3
ABBVIE INC. $40.46 2
Janssen Pharmaceuticals, Inc $16.68 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,569.29 108
PY2019 $1,780.19 105
PY2020 $810.11 42
PY2021 $950.20 62
PY2022 $673.12 37
PY2023 $724.01 35
PY2024 $609.78 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.05 04/25/2024 Food and Beverage Undisputed 01/23/2026 1103278349 CMS
ABBVIE INC. $24.41 05/16/2024 Food and Beverage Undisputed 01/23/2026 1103278351 CMS
Alkermes, Inc. $18.91 02/28/2024 Food and Beverage Undisputed 01/23/2026 1120462958 CMS
Alkermes, Inc. $109.54 03/12/2024 Food and Beverage Undisputed 01/23/2026 1120462960 CMS
Alkermes, Inc. $22.87 06/12/2024 Food and Beverage Undisputed 01/23/2026 1120462962 CMS
Alkermes, Inc. $0.95 12/12/2024 Food and Beverage Undisputed 01/23/2026 1120462964 CMS
Alkermes, Inc. $16.25 12/12/2024 Food and Beverage Undisputed 01/23/2026 1120462966 CMS
Indivior Inc. $25.11 02/13/2024 Food and Beverage Undisputed 01/23/2026 1144524003 CMS
Indivior Inc. $24.10 05/08/2024 Food and Beverage Undisputed 01/23/2026 1144524005 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.34 01/10/2024 Food and Beverage Undisputed 01/23/2026 1143189896 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.33 02/09/2024 Food and Beverage Undisputed 01/23/2026 1143189899 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.99 03/13/2024 Food and Beverage Undisputed 01/23/2026 1143189902 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5.27 04/06/2024 Food and Beverage Undisputed 01/23/2026 1143189906 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.54 04/17/2024 Food and Beverage Undisputed 01/23/2026 1143189909 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5.66 05/09/2024 Food and Beverage Undisputed 01/23/2026 1143189913 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.46 05/28/2024 Food and Beverage Undisputed 01/23/2026 1143189917 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.47 06/26/2024 Food and Beverage Undisputed 01/23/2026 1143189920 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.72 09/20/2024 Food and Beverage Undisputed 01/23/2026 1143189924 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.97 10/19/2024 Food and Beverage Undisputed 01/23/2026 1143189928 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.79 10/29/2024 Food and Beverage Undisputed 01/23/2026 1143189932 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.26 12/05/2024 Food and Beverage Undisputed 01/23/2026 1143189935 CMS
Janssen Pharmaceuticals, Inc $16.68 05/22/2024 Food and Beverage Undisputed 01/23/2026 1078051614 CMS
Lundbeck LLC $16.43 02/21/2024 Food and Beverage Undisputed 01/23/2026 1145895069 CMS
Lundbeck LLC $14.17 04/04/2024 Food and Beverage Undisputed 01/23/2026 1145895071 CMS
Lundbeck LLC $14.17 06/19/2024 Food and Beverage Undisputed 01/23/2026 1145895073 CMS
Neurocrine Biosciences, Inc. $24.79 02/01/2024 Food and Beverage Undisputed 01/23/2026 1150840542 CMS
Neurocrine Biosciences, Inc. $31.85 03/20/2024 Food and Beverage Undisputed 01/23/2026 1150822967 CMS
Otsuka America Pharmaceutical, Inc. $18.44 03/28/2024 Food and Beverage Undisputed 01/23/2026 1118858559 CMS
Otsuka America Pharmaceutical, Inc. $22.38 04/10/2024 Food and Beverage Undisputed 01/23/2026 1118858561 CMS
Otsuka America Pharmaceutical, Inc. $17.36 08/07/2024 Food and Beverage Undisputed 01/23/2026 1118858563 CMS
Otsuka America Pharmaceutical, Inc. $14.72 08/21/2024 Food and Beverage Undisputed 01/23/2026 1118858565 CMS
Otsuka America Pharmaceutical, Inc. $18.80 10/09/2024 Food and Beverage Undisputed 01/23/2026 1118858567 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.